PubMed Health⌕ Search

Biomedical subjects

M Brandis

Publications and source records attributed to M Brandis.

At least 109 records · Page 6Linked to original sources

[Integrative imaging of nephroblastomas and nephroblastomatosis].

Studies on Wilms' tumor have led to intensive investigation of the relationship between nephroblastosis and nephroblastomatosis. Diagnostic strategies have changed: excretory urography is no longer recommended since all information needed is readily obtained by other imaging modalities. Ultrasound is used for the initial examination and confirms the presence and the localization of the mass. CT scan reveals perirenal invasion, and MRI allows the determination of tumor volume and confirmation or exclusion of vascular involvement.

Humans↗

The nephronophthisis complex: clinical and genetic aspects.

Familial juvenile nephronophthisis (NPH) and medullary cystic disease (MCD) are hereditary forms of early-onset chronic renal failure caused by the bilateral formation of cysts at the corticomedullary junction of the kidney. Polyuria, polydipsia, anemia, and growth retardation precede end-stage renal failure. The absence of edema and hypertension frequently leads to a delay in the diagnosis and commencement of therapy. The condition is a major cause of end-stage renal disease (ESRD) in children, accounting for 10%-25% of these patients. About 300 cases of NPH or MCD have been described. Although they are almost indistinguishable clinically and pathologically, the two conditions are separated by a characteristic age of onset (11.5 years in NPH vs. 28.5 years in MCD) and by the mode of inheritance (autosomal recessive in NPH vs. autosomal dominant in MCD). An association of NPH with retinitis pigmentosa is known as the Senior-Løken syndrome (SLS). Hepatic fibrosis, skeletal defects, and central nervous system abnormalities have been described in association with NPH but are typically absent in MCD. Since the pathology of NPH and MCD is similar, the term "nephronophthisis complex" has been introduced to summarize the related diseases. At present, there are no means of identifying heterozygotes, conducting prenatal diagnosis, or screening children in affected families. The histologic changes of NPH are characteristic but not specific for the disease. Cysts of 1-15 mm in diameter, located primarily at the corticomedullary junction, are seen in 70% of the patients. Light microscopy reveals a chronic sclerosing tubulo-interstitial nephropathy.(ABSTRACT TRUNCATED AT 250 WORDS)

Cloning, Molecular↗

Critical care in uraemic children.

The special problems posed by renal disease have to be considered when a uraemic child requires intensive care. This report gives an overview on the problems of dialysis treatment, circulatory support, infectious complications, coagulation disorders and increased intracranial pressure.

Anti-Bacterial Agents↗

[Indications for magnetic resonance tomography of abdominal space-occupying lesions in children].

The frequency of magnetic resonance imaging for investigation of abdominal tumors in childhood is increasing. Malignancies of the liver can be visualized. For benign lesions the accuracy is high particularly in the case of hemangiomas. Magnetic resonance investigations are advisable in the presence of abdominal tumors, in order to differentiate lymph nodes and vascular involvement. Magnetic resonance imaging is mandatory in the case of retroperitoneal and presacral masses to depict any intraspinal tumor spread. RARE myelography can replace computed tomography myelography.

Abdominal Neoplasms↗

Evaluation of local renal function in newborn infants under tobramycin therapy.

Aminoglycosides (AG) provided for less than 5 days to newborn infants do not produce a marked disturbance of glomerular filtration rate (creatinine clearance) or tubular sodium handling (fractional sodium excretion). However, transient disturbances of proximal tubular cell functions can be noted: the excretion of N-acetylglucosaminidase, a lysosomal enzyme, is elevated, and mature not premature infants show a decreased tubular reabsorption of low-molecular-weight proteins during AG treatment. Preliminary investigations show an increased excretion of villin, a structural protein of proximal tubular cells, and a decreased secretion of Tamm-Horsfall protein by the cells of ascending limb of Henle and early distal tubule.

Aminoglycosides↗

Cyclosporine inhibits renal uric acid transport in renal transplants not in children treated for nephrotic syndrome.

Children with various grades of renal insufficiency (CON group) maintained uric acid excretion over a range of glomerular filtration rate (GFR) from 27 to 160 ml/min*1.73m2 despite a decreased filtered load which was paralleled by glomerular filtration of uric acid. This was achieved by a compensatory decrease of net uric acid reabsorption (TUA) and an increasing fractional excretion of uric acid (FEUA) with decreasing GFR. Although there was a decreased GFR in the group of children after transplantation (NTx group) there was no difference in TUA and FEUA between the NTx group and the CON group. Uric acid transport was not affected in children treated with Cyclosporine (CyA) for nephrotic syndrome (NEPH group) compared to the CON group. Decreased fractional phosphate reabsorption in the NTx group suggests proximal tubule damage associated with disturbed uric acid handling. Under conditions of water diuresis hyperuricemia seen in NTx may result from an indirect effect of renal ischemic damage due to the transplantation procedure causing disturbance of proximal tubular uric acid (active) secretion/reabsorption.

Adolescent↗

[Nephrologic aspects of tumor diseases in children].

Renal function disturbances in malignant diseases have various origins. Primary tumorous renal infiltrates and secondary renal function impairment via the tumor lysis syndrome are the most frequent causes. Cytostatic drugs are frequently accompanied by serious nephrotoxic side effects, which can be both acute and chronic. The diagnostic methodology for renal function control is simple and is normally available in any laboratory. The prophylactic measures to prevent serious complications are based on a rigid fluid intake, alkalinization of the urine and careful management of the cytoreductive phase. In addition to acute nephrotoxicity, chronic sequelae of renal disturbances may be an important aspect in future long-time studies.

Child↗

Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.

In a pilot study 23 children with nephrotic syndrome were treated with cyclosporin A (Cs) for 6-45 months. 8 children suffered from steroid dependent minimal change nephrotic syndrome (MCNS) and had experienced at least one course with cytotoxic drugs, but had relapsed thereafter. 2 children had diabetes mellitus type I with nephrotic syndrome and 13 children had steroid resistant focal segmental glomerulosclerosis (FSGS). Cs was started with 100 mg/m2/day in two doses and increased stepwise to obtain a Cs whole blood trough level of 200-400 ng/ml. In steroid dependent MCNS treatment with Cs reduced relapse rate significantly, and prednisone therapy could be stopped completely. After discontinuation of Cs, relapses reoccurred as frequently as before. Renal function remained unimpaired despite repeated Cs treatment courses up to 38 months. In cases of nephrotic syndrome with diabetes type I Cs treatment led to complete remission without changing the insulin requirement. However, after discontinuation of Cs relapses reoccurred. In steroid resistant FSGS 6 children benefited from Cs treatment: 4 went into complete remission, 2 into partial remission. The 2 children with complete remission relapsed but remained Cs responsive. The remaining 7 children with FSGS did not respond to Cs but continued the course of their disease, with two patients rapidly progressing to terminal renal failure. Side-effects of Cs treatment were mild. It is concluded that Cs is an effective agent in steroid dependent MCNS and can be used as an alternative drug in specific cases like steroid toxicity or diabetes mellitus. In steroid resistant FSGS a trial with Cs seems to be warranted since some cases do respond favorably. To avoid nephrotoxicity treatment with Cs should always be monitored closely by determination of blood levels and renal function.

Biopsy↗

Serum creatinine and creatinine clearance in healthy neonates and prematures during the first 10 days of life.

Normal serum creatinine (Scr) and creatinine clearance (Ccr) values during the first 10 days of life were obtained in 63 very premature (28-32 weeks of gestation), premature (33-37 weeks) and term infants (38-42 weeks). Scr fell, and Ccr rose less markedly in the very premature infants. Scr was 80 mumol/l on the 1st day of life both in very premature and premature infants, and 77 mumol/l in full-term neonates. After 10 days, Scr was 73, 53 and 35 mumol/l respectively. There was an exponential correlation between Ccr and gestational age, indicating rapid maturation of glomerular function.

Creatinine↗

N-acetylglutamate synthetase deficiency, a second patient.

A second patient with N-acetylglutamate synthetase deficiency is described. The first symptoms were noted at 6 days of age. The course was lethal despite vigorous treatment. The diagnosis was established after death.

Acetyltransferases↗